Navigation Links
Octapharma Targeting the Major Risk of Hemophilia Treatment - FVIII Antibodies
Date:8/26/2009

art Kreuz, M.D. of the Hemophilia Comprehensive Care Centre at Johann Wolfgang Goethe University Hospital in Frankfurt, Germany. "Successful ITI leads to normalization of the FVIII half-life, allows fully effective on-demand replacement therapy and prophylaxis, with consequent improvement in the patient's quality of life and a marked reduction in the cost of treatment."

The Octapharma-sponsored symposium "From Humans to Humans - Introducing the First Recombinant FVIII Produced From a Human Cell Line" was chaired by Edward G.D. Tuddenham, M.D., Director of The Katharine Dormandy Haemophilia Center & Thrombosis Unit in London, and Johannes Oldenburg, M.D., Ph.D., Chairman and Director of the Institute of Experimental Haematology and Transfusion Medicine in Bonn, Germany.

"Twenty years after the start of clinical trials with rFVIII concentrates expressed by hamster cells, a new rFVIII compound has recently entered clinical studies," Dr. Tuddenham said. "The primary goal behind the development of this new rFVIII was to reduce the overall immunogenic challenge (and resultant inhibitor formation) to the hemophilia patient during rFVIII replacement therapy. An essential part of this strategy was the development of a human rFVIII protein expressed in a human cell-based protein expression system instead of using existing hamster-derived cell lines."

The symposium highlighted the benefits of using a human cell-based protein; preclinical characterizations and some of the functional properties of the first recombinant factor VIII (rFVIII) from a human cell-line; and the planned global clinical development program with the new rFVIII derived from human cells. The investigational new drug application for Octapharma's human cell line rFVIII was filed in the U.S. in May 2008. Clinical trials started in Russia in Spring 2009 and are expected to start in the U.S. later this year. Additionally, Octapharma has other recombin
'/>"/>

SOURCE Octapharma AG
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Octapharma Accepting Applications for Research Grants on Immunotherapy, Coagulation Disorders and Critical Care
2. Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company Octapharma
3. Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
4. Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrines PS-Targeting Antibodies
5. Raptor Pharmaceuticals Provides Update on Targeting Platforms
6. Medarex Receives Milestone Payment for Investigational Antibody Targeting Integrin Receptors
7. MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13
8. Preclinical Study Presented at AACR Annual Meeting Shows Broad Anti-Cancer Potential of Peregrines anti-PS Vascular Targeting Antibodies
9. Dutch Top Institute Allocates 150 Million Euro to R&D Projects Targeting Early Diagnosis and Treatment of Disease
10. Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma
11. MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... DUBLIN , Sept. 19, 2014 Research ... "Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) ... For the purposes of this report, the human ... The human microbiome market is expected to be ... grow at a CAGR of 22.3% within the forecast period ...
(Date:9/19/2014)... , Sept. 19, 2014 UBM Medica ... a leading online community to help oncologists and other ... available regarding the use of targeted therapies and immunotherapies, ... research and treatment.  Every September, ... way to raise awareness about blood cancers—helping to increase ...
(Date:9/19/2014)...  Alere Inc. (NYSE: ALR ), a ... today in support of President Barack Obama,s ... global leader in rapid diagnostics for infectious disease, we ... address the serious threat of antibiotic resistance. We look ... initiatives to promote the development of rapid point-of-care tests ...
Breaking Medicine Technology:Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023 2Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4Alere Applauds President's Executive Order Combating Antibiotic-Resistant Bacteria 2
(Date:9/20/2014)... CA (PRWEB) September 20, 2014 On ... receive a $250,000 pediatric cancer research grant from Hyundai ... Loma Linda University Children’s Hospital located on 11234 Anderson ... work of Dr. Kimberley Payne, Associate Professor at Loma ... work focuses on leukemia in children. , ...
(Date:9/20/2014)... 2014 (HealthDay News) -- As flu season approaches, the ... to get a flu shot and a checkup, according ... care doctor can vaccinate people against the flu, and ... have. Retail stores may provide flu shots for their ... Dr. Jorge Parada, medical director of infection prevention and ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 iFitDress.com, the ... gowns for women, has recently unveiled its new collection ... big sale for special offer on these new outfits; ... shopping season. All customers can now buy cheap ... The company’s sales representative says, “We have extensive experience ...
(Date:9/20/2014)... Recently, UWDress.com, an innovative company that provides many kinds ... launched a special offer for its brand new fashionable ... worldwide clients. Now, all the company’s new and old ... its website. , Additionally, the firm also offers low ... custom made items can be ordered at its website ...
(Date:9/20/2014)... Aliso Viejo, California (PRWEB) September 20, 2014 ... Film Studios have announced the release of the Information theme ... words I would use to describe the Information theme,” says ... been so easy to look so professional.” , Information features ... to change the parameters of the environment. Change the background ...
Breaking Medicine News(10 mins):Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 2Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 3Health News:Get a Flu Shot During Checkup, Doctor Says 2Health News:Fashionable Cocktail Dresses Unveiled Online at iFitDress.com 2Health News:Discounted 2014 Prom Dresses Provided By Innovative Company UWDress.com 2Health News:Today Pixel Film Studios Announced the Release of the Information Theme for Final Cut Pro X 2
... cancer preventing compound in broccoli, first isolated a decade ... broader spectrum of diseases.A new study shows that the ... three days against highly reactive and toxic molecules called ... equivalent of hand to hand combat, broccoli’s compound is ...
... study suggests that the much famed tanning salons, which ... of a number of more common skin cancers. ... Cancer Institute claims to have found a relationship between// ... basal cell carcinoma, squamous cell carcinoma and melanoma. ...
... of drinks is a common problem for heavy drinkers and ... until now.It may support the potentialities of a night out. ... and the Mayo Clinic in Minnesota say the effect of ... in a study of healthy young adults, that blood vessels ...
... in completing its social responsibility. The steps will ... drug. Glaxo is aiding companies cultivate a non-smoking ... providing teams to help in the transition. // ... negotiated for this 'no-smoking' environment, are Housing Development ...
... endoscopies and other complicated medical procedures could be made ... Scientists from the University of California, Los Angeles are ... their environment and are attempting to design computer systems ... use technology that is capable of producing multiple images ...
... cloned cow embryos, scientists say they have constructed miniature kidneys ... master cells called stem cells that have the potential to ... they grew the embryos to the stage where they could ... still unclear whether these made from cloned embryos can perform ...
Cached Medicine News:
... plates in mind, Pipetman Ultra Multichannel ... applications: PCR* sequencing, immunology assays, series ... with Diamond Tips from Gilson's patented ... maximize performance and assure productivity.,* PCR ...
... Focus multichannel pipettes speed ... reagents into microplates, with ... l volumes. The improved ... Focus multichannels, combined with ...
... plates in mind, Pipetman Ultra Multichannel ... applications: PCR* sequencing, immunology assays, series ... with Diamond Tips from Gilson's patented ... maximize performance and assure productivity.,* PCR ...
... Finnpipette Focus multichannel pipettes ... of reagents into microplates, ... 0.1-10 l volumes. The ... Finnpipette Focus multichannels, combined ...
Medicine Products: